Portfolio comparison
Transkaryotic Therapies Inc vs Curevac SE
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Transkaryotic Therapies Inc
Patents indexed
1
Year range
2003
Most recent
2003
biotechpharmaceutical
Top Patents1 enriched
US 6531124· 2003
How to Use Modified Cells to Produce Insulin-Regulating Proteins in the Body
Activity by Decade
2000s1
Company B
Curevac SE
Patents indexed
2
Year range
2024
Most recent
2024
biotechpharmaceuticaloncologygene_editingimmunotherapy
Top Patents2 enriched
US 12048738· 2024
Using mRNA to Teach the Body to Fight Prostate Cancer
US 12083190· 2024
How an mRNA Vaccine Teaches Your Body to Fight Rabies
Activity by Decade
2020s2
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.